US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 30, 2024 (2 years ago)

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Content Uniformity Specifications

What was recalled

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-407-03
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0559-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cefixime recalls

See all